Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,942.00    -70.00 (-2.32%)
Bid:
2,944.00
Ask:
2,946.00
Spread: 2.00 (0.068%)
Market Cap: £6.97b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Executive Committee change

22 Jan 2018 07:00

RNS Number : 4559C
IMI PLC
22 January 2018
 

22 January 2018

Executive Committee change

 

IMI plc (the "Group" or "IMI") announces the following changes to its Executive Committee.

Peter Spencer, Divisional Managing Director of IMI Hydronic Engineering and a member of the Executive Committee, has left the Group. An external search process to identify his successor is underway.

In the interim Phil Clifton, who recently joined IMI, will lead the Hydronic Engineering division as Interim Managing Director, overseen by Mark Selway, until a permanent Divisional Managing Director is appointed. Phil will also become a member of IMI's Executive Committee.

Phil has extensive commercial experience in the engineering sector. Previously he was Chief Executive of Signum Technology, the private equity backed specialist engineering group focused on flow control sectors. Prior to that he spent nearly seven years with The Weir Group PLC where he was Divisional Managing Director of the company's Power & Industrial division between 2007 and 2011. With a proven track record of driving significant growth, particularly in challenging market environments, Phil's skills will help us to capitalise on the Division's strong foundations and increase focus on its commercial opportunities.

Mark Selway, Chief Executive of IMI, commented "On behalf of the Board and the Executive Committee I would like to thank Peter for all his hard work and dedication since he joined IMI over seven years ago. He has made a significant contribution to the business and, in particular, he has helped transform the Hydronic division into a more focused and efficient organisation. Furthermore, he has overseen the creation of a number of new product ranges. We continue to execute the existing strategy for Hydronic Engineering, with a focus on opportunities for accelerated growth."

Preliminary results announcement

As previously advised, the Group's preliminary results announcement for the full year ended 31 December 2017, will be issued on 2 March 2018.

Expectations in relation to the Group's 2017 full year results, as outlined at the time of the November 2017 Interim Management Statement, remain unchanged, albeit the results from the IMI Hydronic Engineering division are likely to be lower than previously anticipated.

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Suzanne Bartch / Gayden Metcalfe

Teneo Blue Rubicon

Tel: +44 (0)203 757 9239

 

Notes to editors

IMI plc

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. IMI has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFDFAUFASEIF
Date   Source Headline
1st May 202010:03 amRNSTotal Voting Rights
30th Apr 20204:48 pmRNSHolding(s) in Company
27th Apr 20205:27 pmRNSDisclosure of rights attached to equity shares
21st Apr 20201:07 pmRNSChange of Venue for the 2020 AGM
21st Apr 202012:30 pmRNSDirector Declaration
16th Apr 20204:26 pmRNSHolding(s) in Company
15th Apr 20202:20 pmRNSDirector/PDMR Shareholding
14th Apr 20204:42 pmRNSDirector/PDMR Shareholding
1st Apr 20209:56 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSCoronavirus update
26th Mar 20203:58 pmRNSHolding(s) in Company
18th Mar 20204:56 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSDirector/PDMR Shareholding
12th Mar 202010:52 amRNSDirector/PDMR Shareholding
11th Mar 202012:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:10 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSPreliminary results, year ended 31 December 2019
12th Feb 20203:07 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:55 amRNSTotal Voting Rights
15th Jan 202012:15 pmRNSDirector/PDMR Shareholding
13th Jan 20203:31 pmRNSHolding(s) in Company
3rd Jan 202011:54 amRNSBlock listing Interim Review
2nd Jan 20202:04 pmRNSTotal Voting Rights
11th Dec 20192:40 pmRNSDirector/PDMR Shareholding
2nd Dec 201910:20 amRNSTotal Voting Rights
27th Nov 20199:00 amRNSNon-executive director changes
21st Nov 20198:10 amRNSDirector/PDMR Shareholding
14th Nov 201910:04 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSIMS and Strategy Review conclusions
1st Nov 201910:04 amRNSTotal Voting Rights
9th Oct 20192:07 pmRNSDirector/PDMR Shareholding
1st Oct 201910:17 amRNSTotal Voting Rights
23rd Sep 20197:00 amRNSCompletion of PBM acquisition
16th Sep 20193:51 pmRNSDirector/PDMR Shareholding
11th Sep 20191:08 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:18 amRNSTotal Voting Rights
20th Aug 20197:00 amRNSProposed acquisition of PBM for $85m
14th Aug 20191:42 pmRNSDirector/PDMR Shareholding
12th Aug 20193:40 pmRNSNon-executive director change
1st Aug 20194:17 pmRNSTotal Voting Rights
26th Jul 20197:00 amRNSInterim Results, six months ended 30 June 2019
15th Jul 20194:29 pmRNSDirector Declaration
10th Jul 20192:03 pmRNSDirector/PDMR Shareholding
4th Jul 20194:07 pmRNSBlock listing Interim Review
1st Jul 201910:35 amRNSTotal Voting Rights
12th Jun 201912:38 pmRNSDirector/PDMR Shareholding
10th Jun 20193:18 pmRNSDirector/PDMR Shareholding
3rd Jun 201910:24 amRNSTotal Voting Rights
20th May 20193:18 pmRNSDirector/PDMR Shareholding
15th May 201912:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.